Vitamin D3-retinoid X receptor dimerization, DNA binding, and transactivation are differentially affected by analogs of 1,25-dihydroxyvitamin D3
- PMID: 8614417
- DOI: 10.1210/mend.9.12.8614417
Vitamin D3-retinoid X receptor dimerization, DNA binding, and transactivation are differentially affected by analogs of 1,25-dihydroxyvitamin D3
Abstract
A number of analogs of 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] have been synthesized that act as more potent inducers of cellular differentiation and inhibitors of cell growth than the natural ligand; at the same time, many of the analogs have reduced hypercalcemic properties. This combination makes these compounds attractive candidates for clinical use. The mechanism by which the analogs act, however, is unclear. Potentially, the analogs could be taken up more readily, be more slowly catabolized, or have higher binding affinities for the vitamin D receptor (VDR). Analogs of 1,25-(OH)2D3 could also differentially modulate one or more of the activities of VDR, namely dimerization, DNA binding, and/or transcriptional regulation. To directly examine this latter possibility, we used a sensitive assay for the kinetics of dimerization and DNA binding, surface plasmon resonance, and report here that three 1,25-(OH)2D3 analogs, 1,25-(OH)2-16-ene-23-yne-D3, 1,25-(OH)2-16-ene-23-yne-26,27-di home-D3, and 1,25-(OH)2-26,27-hexafluoro-16-ene-23-yne-D3, all confer distinct rate and equilibrium constants for VDR-retinoid X receptor heterodimerization and DNA binding to a specific vitamin D response element relative to the natural ligand. In response to the hexafluoro analog, the apparent Kd for DNA binding by VDR was significantly lower than that for 1,25-(OH)2D3, and correspondingly, in vivo transactivation from a responsive reporter was greater. Interestingly, solution heterodimerization was not affected by this analog. These results suggest that vitamin D analogs do indeed confer biological effects by acting directly and differentially at the level of VDR, and that specific vitamin D analogs can act on distinct receptor functions.
Similar articles
-
Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.J Bone Miner Res. 2001 Apr;16(4):625-38. doi: 10.1359/jbmr.2001.16.4.625. J Bone Miner Res. 2001. PMID: 11315990
-
Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system.Mol Endocrinol. 1997 Mar;11(3):366-78. doi: 10.1210/mend.11.3.9895. Mol Endocrinol. 1997. PMID: 9058382
-
Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.Leuk Res. 1995 Mar;19(3):147-58. doi: 10.1016/0145-2126(94)00127-v. Leuk Res. 1995. PMID: 7700077
-
The vitamin D hormone and its nuclear receptor: molecular actions and disease states.J Endocrinol. 1997 Sep;154 Suppl:S57-73. J Endocrinol. 1997. PMID: 9379138 Review.
-
Genomic actions of 1,25-dihydroxyvitamin D3.J Nutr. 1995 Jun;125(6 Suppl):1690S-1694S. doi: 10.1093/jn/125.suppl_6.1690S. J Nutr. 1995. PMID: 7782928 Review.
Cited by
-
A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system.Genes Dev. 1998 Jun 15;12(12):1787-800. doi: 10.1101/gad.12.12.1787. Genes Dev. 1998. PMID: 9637681 Free PMC article.
-
Ligand-binding regulation of LXR/RXR and LXR/PPAR heterodimerizations: SPR technology-based kinetic analysis correlated with molecular dynamics simulation.Protein Sci. 2005 Mar;14(3):812-22. doi: 10.1110/ps.04951405. Protein Sci. 2005. PMID: 15722453 Free PMC article.
-
Proposed mechanism for the stabilization of nuclear receptor DNA binding via protein dimerization.Mol Cell Biol. 1997 Nov;17(11):6546-54. doi: 10.1128/MCB.17.11.6546. Mol Cell Biol. 1997. PMID: 9343418 Free PMC article.
-
Vitamin D and its analogs in chronic renal failure.Osteoporos Int. 1997;7 Suppl 3:S202-8. doi: 10.1007/BF03194373. Osteoporos Int. 1997. PMID: 9536333 Review. No abstract available.
-
TRPV6 determines the effect of vitamin D3 on prostate cancer cell growth.PLoS One. 2011 Feb 11;6(2):e16856. doi: 10.1371/journal.pone.0016856. PLoS One. 2011. PMID: 21347289 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources